How can cancer cells be targeted without damaging healthy tissue? This is one of the major challenges facing oncology today.

A team from UNIGE has designed a molecular system that distinguishes and neutralizes cancer cells with unprecedented ...

Symeres has entered a collaboration with Ambagon Therapeutics on molecular glue research in colorectal cancer, aiming to ...

Like tiny superheroes, small, naturally occurring segments of RNA can block multiple molecular paths that cancer cells use to ...

As the second leading cause of death globally, cancer is a worldwide health crisis, particularly as life expectancies continue to increase. In its final stages, cancer spreads throughout the body in a ...

UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...

A panelist discusses how multiple molecular biomarkers beyond BRCA and homologous recombination deficiency (HRD) testing are emerging as important for guiding ovarian cancer therapy, including ...

Durability of Response With Selpercatinib in Patients With RET-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001 The question of whether to change tumor naming is a very ...

When patients develop a narrowing or blockage in the bile ducts – the tubes connecting the liver, gallbladder and intestines – physicians must ...

Mythreye Karthikeyan, Ph.D., an associate professor in the Division of Molecular and Cellular Pathology, has been appointed Co-Leader of the UAB O'Neal Comprehensive Cancer Center's Cancer Biology and ...